DLAT Antikörper (C-Term)
-
- Target Alle DLAT Antikörper anzeigen
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Bindungsspezifität
- AA 587-617, C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DLAT Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- DLAT, CT (DLAT, DLTA, Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, 70kD mitochondrial autoantigen of primary biliary cirrhosis, Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex, M2 antigen complex 70kD subunit, Pyruvate dehydrogenase complex component E2)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- DLAT antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 587-617 amino acids from the C-terminal region of human DLAT.
- Isotyp
- IgG
- Top Product
- Discover our top product DLAT Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
- Andere Bezeichnung
- DLAT (DLAT Produkte)
- NCBI Accession
- NP_001922
- UniProt
- P10515
-